Topic:

April 2024

If you’re moderately to severely immunocompromised due to disease or treatment,

If you’re moderately to severely immunocompromised due to disease or treatment, you may have a lower immune response to COVID-19 vaccination. NACI recommends you get an additional mRNA vaccine dose following your 1- or 2-dose vaccine series. The additional dose should be given at least 28 days after the second dose. A booster dose may be recommended at least 6 months after the third dose. For more information on COVID-19 vaccines and dosage, consult a health care provider about what’s best for you.

Please visit https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/how-vaccinated.html for more details.

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Anifrolumab Now Covered Under BC PharmaCare for Lupus Treatment

Read

Belimumab for Lupus Nephritis in BC Now Approved Under BC Renal Formulary

Read

Lupus Treatment and Access Across Provinces: Take the Patient Survey

Read